Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hang Su

Showing results (791-800 of 830) with videos related to

Pageof 83
Sort By:
BMC Cancer|January 24, 2024
Long-term outcomes with HLX01 (HanliKang<sup>®</sup>), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyYan Qin, Yongping Song, Dong Wang, et al.
Nature Communications|September 22, 2022
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadthZhiqiang Ku, Xuping Xie, Jianqing Lin, et al.
Faraday Discussions|December 7, 2020
Multiphase chemistry experiment in Fogs and Aerosols in the North China Plain (McFAN): integrated analysis and intensive winter campaign 2018Guo Li, Hang Su, Nan Ma, et al.
Annals of Hematology|May 28, 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in ChinaWei Wang, Wei Zhang, Li-Ping Su, et al.
Cell Reports|March 21, 2023
Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunityHaipeng Liu, Hang Su, Fei Wang, et al.
JCI Insight|November 8, 2022
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cellsKim Anthony-Gonda, Alex Ray, Hang Su, et al.
Nature Communications|May 10, 2023
Unified theoretical framework for black carbon mixing state allows greater accuracy of climate effect estimationJiandong Wang, Jiaping Wang, Runlong Cai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2018
Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Xiu-Wen Deng, Jun-Xin Wu, Tao Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
Cancer Medicine|October 26, 2018
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Bo Chen, Su-Yu Zhu, Mei Shi, et al.
Pageof 83

Showing results (791-800 of 830) with videos related to

Sort By:
Pageof 83
BMC Cancer|January 24, 2024
Long-term outcomes with HLX01 (HanliKang<sup>®</sup>), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyYan Qin, Yongping Song, Dong Wang, et al.
Nature Communications|September 22, 2022
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadthZhiqiang Ku, Xuping Xie, Jianqing Lin, et al.
Faraday Discussions|December 7, 2020
Multiphase chemistry experiment in Fogs and Aerosols in the North China Plain (McFAN): integrated analysis and intensive winter campaign 2018Guo Li, Hang Su, Nan Ma, et al.
Annals of Hematology|May 28, 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in ChinaWei Wang, Wei Zhang, Li-Ping Su, et al.
Cell Reports|March 21, 2023
Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunityHaipeng Liu, Hang Su, Fei Wang, et al.
JCI Insight|November 8, 2022
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cellsKim Anthony-Gonda, Alex Ray, Hang Su, et al.
Nature Communications|May 10, 2023
Unified theoretical framework for black carbon mixing state allows greater accuracy of climate effect estimationJiandong Wang, Jiaping Wang, Runlong Cai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2018
Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Xiu-Wen Deng, Jun-Xin Wu, Tao Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
Cancer Medicine|October 26, 2018
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)Bo Chen, Su-Yu Zhu, Mei Shi, et al.
Pageof 83